Marijuana Stocks & Public Companies

Marijuana Business Stock Ticker

Chris Walsh  | April 30, 2015
More than 100 marijuana stocks are currently listed on NASDAQ. Click to see our chart of the most relevant ones.

Medical Marijuana Inc. Partners With CannaNative on CBD Product

John Schroyer  | August 15, 2016

California-based Medical Marijuana Inc. and Native American company CannaNative have put together a hemp-derived CBD product line to be sold on tribal lands.

The companies said in a news release Monday that Medical Marijuana Inc. and its HempMeds subsidiary will produce the product line, which will be sold under the CannaNative brand.

It will …

Canadian Cannabis Company’s Move to Large Stock Exchange Could Create Positive Ripple Effect

Omar Sacirbey  | August 10, 2016

By Omar Sacirbey

Canada-based Canopy Growth recently made history when it began trading on the Toronto Stock Exchange, becoming the first marijuana cultivator to list on a major North American exchange.

The move could spur more Canadian – and possibly even U.S. – medical cannabis companies to list on the exchange, one of the world’s largest.

Canadian MJ Companies Raise Tens of Millions in Financing

John Schroyer  | August 8, 2016

Within the span of a week and a half, a trio of Canadian medical cannabis producers announced they had all raised seven-figure amounts to expand their businesses.

First it was Aphria, which revealed on July 28 that it had entered into a “bought deal” that would net it CA$25 million, in exchange for …

CO Online Wholesaler Partnering With Cannabis Software Firms

John Schroyer  | August 1, 2016

Colorado-based online wholesale platform Cannabase has entered into exclusive partnerships with seed-to-sale tracking software companies MJ Freeway and BioTrackTHC.

The partnership, announced by the companies, will bring new weight to Cannabase’s pricing and inventory information, given that it will now be backed by MJ Freeway’s and BioTrackTHC’s data. In a pair …

Canadian MJ Grower to List on Major Stock Exchange

Omar Sacirbey  | July 27, 2016

In what could be a first in both the cannabis industry and stock market history, a large marijuana cultivation company will list on a major North American stock exchange.

Canopy Growth Corp., one of Canada’s biggest licensed medical marijuana companies, started trading on the Toronto Stock Exchange (TMX) Tuesday under the ticker symbol …

Australian MMJ Company Aims to Raise $4M for Human Trials

Omar Sacirbey  | July 18, 2016

A publicly traded Australian pharmaceutical and biotech company that recently entered the medical marijuana sector aims to raise about $4.1 million (AUS $5.4 million) to support MMJ trials on human subjects.

If successful, Medlab Clinical plans to spend the money to accelerate a program of human trials of cannabis-based pain management therapy for …

Week in Review: California is Official, GW’s Epilepsy Drug & Illinois Resignation

John Schroyer  | July 1, 2016

By Omar Sacirbey and John Schroyer

California’s recreational marijuana campaign makes the November ballot, GW Pharmaceuticals’ MJ-based epilepsy drug could play a role in DEA rescheduling, and a possible new dawn in Illinois’ medical cannabis program.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

Medical Cannabis Company GW Pharma’s Stock Again Jumps

John Schroyer  | June 27, 2016

GW Pharmaceuticals – a publicly traded British medical cannabis company conducting clinical trials to determine how effective its medications are against epilepsy – watched its stock surge once again in response to a successful round of testing.

News Monday that a phase 3 trial was helpful at treating patients with Lennox-Gastaut Syndrome, a type …

Chart of the Week: Monthly Recreational Marijuana Sales in U.S. Averaging $124M

Chris Walsh  | June 27, 2016

By Eli McVey

Colorado, Oregon and Washington State are averaging a combined $123.5 million in monthly recreational marijuana sales so far this year, putting the industry on pace to rack up at least $1.5 billion in adult-use cannabis revenue at the retail level in 2016.